234 BATH ROAD, SLOUGH, BERKSHIRE, X0
Investor Presentation
Material disclosure
Announces $175 Million Accelerated Share Repurchase
Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
Annual Report to Security Holders
Indivior Pharmaceuticals Issues $500 Million Convertible Senior Notes
Other Events
Announces Proposed Convertible Senior Notes Offering
Q1
FY 2024
Q3
Q2
Annual and Transition Report of Foreign Private Issuers
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Notice of Suspension of Duty to File Reports
Additional Proxy Materials
Definitive Proxy Statement
Definitive Additional Information Statement
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
S-8 POS